ESLAW ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM)
- 0.091
- 0.0000.00%
3: Initial statement of beneficial ownership of securities-Director Zhang Hong
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | SC 13D: Statement of acquisition of beneficial ownership by individuals-Eureka Therapeutics, Inc.(71.8%)
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3: Initial statement of beneficial ownership of securities-Chief Financial Officer Xu Jiandong
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3: Initial statement of beneficial ownership of securities-Director Roberts Marsha
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3: Initial statement of beneficial ownership of securities-Director Xu Pei
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3: Initial statement of beneficial ownership of securities-Chief Executive Officer Liu Cheng
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3: Initial statement of beneficial ownership of securities-Director Wu Xuejun Janelle
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3: Initial statement of beneficial ownership of securities-Director Wu Fan
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 3: Initial statement of beneficial ownership of securities-10% Owner Eureka Therapeutics, Inc.
ESTRELLA IMMUNOPHARMA INC C/WTS 09/29/28(TO PUR COM) | 4: Statement of changes in beneficial ownership of securities-10% Owner Owl Creek Asset Management, L.P.